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Reply to the Editor." 
My colleagues and I thank Drs. Sakakibara nd Mitsui 
for their interest in our work and for raising the important 
question of the effluent return to the systemic irculation. 
Undoubtedly, the venous effluent of limbs reperfused 
after several hours of complete ischemia contains greater 
amounts of myoglobin, free hemoglobin, creatine kinase, 
and potassium than do control limbs. After complete 
ischemia, this has been shown in experimental 1 and 
clinical 2studies. To a lesser degree, this increase was also 
measurable after revascularization for incomplete isch- 
emia. 3
These components in the venous effluent are a conse- 
quence of the severe local damage of skeletal muscle 
(rhabdomyolysis, edema) and are the cause for systemic 
complications (hyperkalemia, myoglobinemia, cute renal 
failure, acidosis, multiorgan failure, and death) following 
revascularization after prolonged periods of  limb isch- 
emia. 
Our limb reperfusion strategy has been developed to 
decrease the skeletal muscle reperfusion injury after re- 
vascularizations for prolonged ischemia. Less local dam- 
age will result in reduced concentrations of potassium, 
creatine kinase, and hydrogen ions in the venous effluent, 
which could be demonstrated in an experimental study. 1
Nevertheless, the venous effluent, even after controlled 
limb reperfusion, still contains ignificant amounts of end 
products of the rhabdomyolysis, which can only be pre- 
vented from entering the systemic irculation by discard- 
ing the venous effluent. Simply discarding the venous 
effluent is not possible because of the large amount of 
blood that would be lost. The same is true for any filtering 
process. The only possibility is to separately cannulate the 
femoral arteries and veins and use an extracorporeal 
circulation including oxygenat0r and roller pumps. This 
approach was recently described by Vogt and coworkers 2 
from the Zfirich group in a patient with complete ischemia 
for 24 hours. 
The concentrations of myoglobin, potassium, and crea- 
tine kinase in the venous effluent are related to the 
severity of ischemia (complete/incomplete) (1/3) and the 
duration of ischemia (2/4). The more severe the ischemic 
insult, the more pronounced is the reperfusion damage, 
resulting in higher concentrations in the venous effluent. 
In our three-center study, 4 we were able to reduce the 
concentrations of myoglobin, potassium, and creatine 
kinase to a level that did not produce systemic hyperka- 
lemia or renal failure. However, Vogt and coworkers 2 
have used a complete xtracorporeal circuit (including an 
oxygenator) for a patient with complete ischemia for 24 
hours and achieved excellent results with this approach. In 
patients with complete ischemia exceeding 24 to 36 hours, 
it might very well be necessary to discard the venous 
effluent and use an extracorporeal circuit to prevent 
severe systemic side effects. In our study with a mean 
ischemic time of 26 hours (range 6 to 39 hours), we did see 
systemic increases in potassium, creatine kinase, creati- 
nine, and blood urea nitrogen; however, this did not 
produce remote organ failure. Even though we did not 
measure myoglobin concentrations in our patients, the 
fact that none had severe renal failure shows that there 
was no major renal tubular dysfunction. 
Ideally, future refinements in the technique of con- 
trolled limb reperfusion will elucidate criteria, identify 
which patients will need controlled limb reperfusion with- 
out complete xtracorporeal circulation, and define those 
patients who need controlled reperfusion with venous 
effluent discardment. 
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Failure of devices used for the closure of atrial 
septal defects 
To the Editor." 
I read with interest he report of Agarwal, Ghosh, and 
Mittal 1 on the surgical management of unsuccessful atrial 
septal defect (ASD) closures with the AngelWings device 
(Microventa Corp., White-Bear Lake, Minn.). These clo- 
sures were performed by me as a part of the International 
ASD Closure Trial, which is being organized by the 
University of Minnesota to evaluate the feasibility, safety, 
and efficacy of a new percutaneous device 2 developed at 
the University of Minnesota. Our preliminary clinical 
experience in the first 100 patients (including the six 
reported by Agarwa!, Ghosh, and Mittal 1) has been 
submitted for publication. The overall procedural success 
rate is 90%. We have learned a large number of lessons in 
the clinical use of this device from the more than 100 
patients who have undergone this procedure. 
The reason for emergency surgery for retrieval of errant 
devices has been the difficulty in retrieving the device, 
which is made of a nitinol alloy framework with a high 
tensile strength. Although we have demonstrated our 
ability to retrieve the device with snares in animal mod- 
els, a the stiff wire can potentially perforate cardiac ham- 
bers and systemic veins. The overriding concern in the 
clinical trials has been that of patient safety and hence the 
adoption of a policy of surgical removal of unsuccessfully 
deployed evices and closure of defects. We have concur- 
rently developed a system for retrieving these devices 
safely. Once this is made available to participating centers, 
